Device-Detected Subclinical Atrial Fibrillation in the Wearable Era: When Is Anticoagulation Justified? Review Abstract Background Consumer wearables, ambulatory electrocardiographic monitors, pacemakers, implantable cardioverter-defibrillators, and implantable cardiac monitors are increasingly identifying brief and asymptomatic atrial arrhythmias. However, a photoplethysmography-based irregular-rhythm notification is not equivalent to a diagnosis
Author: Nancy Ogbonna
CIDP Overdiagnosis and IVIG Stewardship: Are We Treating the Right Patients for the Right Duration?
CIDP Overdiagnosis and IVIG Stewardship: Are We Treating the Right Patients for the Right Duration? Review Abstract Background Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a highly treatable immune-mediated neuropathy. However, establishing the diagnosis requires a careful integration of the clinical phenotype, electrodiagnostic findings, appropriate supportive evidence,
Frailty Before the ICU: Using Frailty Scores to Guide Escalation Without Turning Them Into Gatekeepers
Frailty Before the ICU: Using Frailty Scores to Guide Escalation Without Turning Them Into Gatekeepers Review Abstract Purpose: Frailty has emerged as an important predictor of adverse outcomes in hospitalized and critically ill adults, particularly among older patients with multiple chronic conditions. As healthcare systems increasingly care
Melanoma Screening in the AI Era: Why Dermatologists Remain the Clinical Standard and AI Should Stay an Adjunct
Melanoma Screening in the AI Era: Why Dermatologists Remain the Clinical Standard and AI Should Stay an Adjunct Review Abstract Purpose: Melanoma remains one of the most aggressive forms of skin cancer, accounting for a disproportionate number of skin cancer related deaths despite representing a relatively small
Resistant Hypertension Gets Personal: Aldosterone, Renin, and the Renewed Secondary Workup
Resistant Hypertension Gets Personal: Aldosterone, Renin, and the Renewed Secondary Workup Review Abstract Purpose: Resistant hypertension remains a significant clinical challenge and is associated with a markedly increased risk of cardiovascular disease, chronic kidney disease progression, stroke, heart failure, and premature mortality. Despite the availability of multiple
Vaccines and Catch-Up in 2026: Schedule Navigation, Documentation, and Vaccine Confidence for Clinicians
Vaccines and Catch-Up in 2026: Schedule Navigation, Documentation, and Vaccine Confidence for Clinicians Review Abstract Purpose: This review provides a comprehensive overview of contemporary vaccine practice in 2026, with emphasis on immunization schedule navigation, catch up vaccination, documentation standards, vaccine safety, product specific recommendations, and evidence based communication
Vestibular Migraine in Neurology Clinics: The Great Mimicker Behind Recurrent Vertigo
Vestibular Migraine in Neurology Clinics The Great Mimicker Behind Recurrent Vertigo Review Abstract Purpose: Vestibular migraine is increasingly recognized as one of the most common neurological causes of recurrent episodic vertigo and dizziness, yet it remains substantially underdiagnosed and frequently misclassified in routine clinical practice. Patients
Quantitative Neuromuscular Monitoring: Why Are We Still Guessing at Recovery?
Quantitative Neuromuscular Monitoring Why Are We Still Guessing at Recovery Review Abstract Purpose: This review critically evaluates the scientific rationale, current evidence, professional guideline recommendations, and practical implementation of quantitative neuromuscular monitoring during recovery from neuromuscular blockade, with particular emphasis on patients receiving nondepolarizing neuromuscular blocking
HIV in the Era of Long-Acting Injectables: Redefining Adherence Without Abandoning Follow-Up
HIV in the Era of Long-Acting Injectables: Redefining Adherence Without Abandoning Follow-Up Reviewed and updated July 29, 2026 Abstract Purpose: This review examines how long-acting injectable antiretroviral therapy and injectable HIV pre-exposure prophylaxis are changing treatment, prevention, and adherence frameworks in HIV care. Methodology: The
Menin Inhibitors in AML: Targeting KMT2A-Rearranged and NPM1-Mutated Disease
Menin Inhibitors in AML: Targeting KMT2A-Rearranged and NPM1-Mutated Disease Review Abstract Purpose Acute myeloid leukemia (AML) is a heterogeneous group of hematologic malignancies defined increasingly by recurrent molecular and cytogenetic abnormalities. KMT2A rearrangements and NPM1 mutations identify biologically distinct leukemias that frequently rely on menin-dependent
